{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:14:58Z","timestamp":1759882498269,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA 010325","R01 DA 017711","T32 DA007304"],"award-info":[{"award-number":["R01 DA 010325","R01 DA 017711","T32 DA007304"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.drugalcdep.2006.02.004","type":"journal-article","created":{"date-parts":[[2006,3,16]],"date-time":"2006-03-16T07:17:02Z","timestamp":1142493422000},"page":"206-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine"],"prefix":"10.1016","volume":"84","author":[{"given":"William W.","family":"Stoops","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua A.","family":"Lile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E.A.","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig R.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2006.02.004_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","article-title":"Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors","volume":"302","author":"Burris","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2006.02.004_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0165-6147(99)01422-4","article-title":"Dopamine receptor partial agonists could address the duality of cocaine craving","volume":"21","author":"Childress","year":"2000","journal-title":"Trend. Pharmacol. Sci."},{"key":"10.1016\/j.drugalcdep.2006.02.004_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00004714-200006000-00003","article-title":"Risperidone for the treatment of cocaine dependence: randomized, double-blind trial","volume":"20","author":"Grabowski","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2006.02.004_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0376-8716(03)00009-7","article-title":"A pilot trial of olanzapine for the treatment of cocaine dependence","volume":"70","author":"Kampman","year":"2003","journal-title":"Drug. Alcohol. Depend."},{"year":"2000","series-title":"Psychiatric Drugs","author":"Lieberman","key":"10.1016\/j.drugalcdep.2006.02.004_bib5"},{"key":"10.1016\/j.drugalcdep.2006.02.004_bib6","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/sj.npp.1300803","article-title":"Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of d-amphetamine in humans","volume":"30","author":"Lile","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2006.02.004_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1037\/1064-1297.6.1.32","article-title":"Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans","volume":"6","author":"Rush","year":"1998","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2006.02.004_bib8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/01.jcp.0000130553.55630.ad","article-title":"Alprazolam attenuates the discriminative-stimulus effects of d-amphetamine in humans","volume":"24","author":"Rush","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2006.02.004_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/jpet.102.048439","article-title":"Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans","volume":"306","author":"Rush","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2006.02.004_bib10","unstructured":"Substance Abuse and Mental Health Services Administration, 2003. National Survey on Drug Use and Health (NSDUH). http:\/\/www.samhsa.gov."},{"key":"10.1016\/j.drugalcdep.2006.02.004_bib11","unstructured":"Substance Abuse and Mental Health Services Administration, 2004. National Survey on Drug Use and Health (NSDUH). http:\/\/www.samhsa.gov."},{"key":"10.1016\/j.drugalcdep.2006.02.004_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2005.06.010","article-title":"Medications development: successes and challenges","volume":"108","author":"Vocci","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2006.02.004_bib13","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1523\/JNEUROSCI.21-23-09414.2001","article-title":"Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence","volume":"21","author":"Volkow","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2006.02.004_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0022-3565(24)35115-8","article-title":"Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors","volume":"291","author":"Volkow","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2006.02.004_bib15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0006-8993(92)91327-B","article-title":"Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration","volume":"593","author":"Weiss","year":"1992","journal-title":"Brain Res."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871606000615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871606000615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:50:55Z","timestamp":1759827055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871606000615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0376871606000615"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.02.004","relation":{},"ISSN":["0376-8716"],"issn-type":[{"type":"print","value":"0376-8716"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}